Bluemtec Co (XKRX:439580) ROCE % : 23.03% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bluemtec Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 23.03%.

Bluemtec Co ROCE % Historical Data

The historical data trend for Bluemtec Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co ROCE % Chart

Bluemtec Co Annual Data

Trend

Dec20

Dec21

Dec22

ROCE %

-21.31

-468.49

Bluemtec Co Quarterly Data
	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial			-663.08	0.44	-0.61	-21.23	23.03

Bluemtec Co ROCE % Calculation

Bluemtec Co's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-13022.147	/	( ( (25628.6 - 28438.809)	+	(40362.695 - 31993.305) )	/ 2 )
	=	-13022.147	/	( (-2810.209	+	8369.39)	/ 2 )
	=	-13022.147	/	2779.5905
	=	-468.49 %

Bluemtec Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	12337.84	/	( ( (92236.122 - 37584.864)	+	(88011.025 - 35494.675) )	/ 2 )
	=	12337.84	/	( ( 54651.258	+	52516.35 )	/ 2 )
	=	12337.84	/	53583.804
	=	23.03 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Bluemtec Co (XKRX:439580) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bluemtec Co ROCE % Related Terms

Thank you for viewing the detailed overview of Bluemtec Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bluemtec Co (XKRX:439580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 322-2, 322-2A, 184, Jungbu-daero, Giheung-gu , Gyeonggi-do, 1612, 1613, 1614, 1615 Yeongdeok-dong, Hicks U Tower, Yongin-si, KOR

Website

https://www.bluemtec.co.kr

Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co (XKRX:439580) Headlines

No Headlines